AMP Members Reiterate Position on LDT Regulation; Questions to FDA Suggest Confusion Remains | GenomeWeb

NATIONAL HARBOR, Md. (GenomeWeb) — At the annual meeting of the Association for Molecular Pathology here this week, attendees gathered for a question and answer session with US Food and Drug Administration officials Alberto Gutierrez and Elizabeth Mansfield, who fielded 45 minutes of queries on the scope and details of the FDA's draft guidance on the regulation of laboratory developed tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.